Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Accure Therapeutics logo — R&D pharma dedicated to developing innovative medicines to t...

Accure Therapeutics

R&D pharma dedicated to developing innovative medicines to treat patients suffering from Central nervous system diseases

Founded 2020 Spain Spain 12 employees Grant Total: $9.20M Biotechnology, Health Care +1

General Information

Company Name Accure Therapeutics
Founded Year 2020
Location Spain Spain +1
Founders / Decision Makers
Team member
Employees 12
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Grant
Social

Get notified when Accure Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Accure Therapeutics

Accure Therapeutics is a R&D pharma company with a focus on developing innovative medicines for patients suffering from severe central nervous system diseases. The company's mission is to impede the degeneration and death of dysfunctional neurons and their glial support system. By developing Disease Modifying Therapies, Accure Therapeutics aims to correct pathological changes responsible for diseases such as Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease, and Epilepsy. Since its founding in 2020 in Spain, the company has attracted $1.60M in its latest investment round, led by the Michael J. Fox Foundation and the Luxembourg National Research Fund. With a strong industry presence in Biotechnology, Health Care, and Health and Wellness, Accure Therapeutics is positioned to make significant contributions in treating central nervous system diseases.

Taxonomy: neuroprotection, multiple sclerosis, optic neuritis, Parkinson's disease, epilepsy, CNS diseases, pharmaceutical industry, remyelination, rare diseases, neuromyelitis optica, drug development, clinical research, neurobiology, innovative medicine, central nervous system

Services & Products

Research and development of innovative medicines for CNS diseases

Target Customers

Patients suffering from Central Nervous System (CNS) diseases

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Select •••••• 2 •••• •••• 07 Apr 2025
Series A •••••• 3
Investor Investor
•••• •••• 		26 May 2020

Latest News

View All
Accure Therapeutics secures $1.6M from Michael J. Fox Foundation and Luxembourg national research Fu... — Tech
Accure Therapeutics secures $1.6M from Michael J. Fox Foundation and Luxembourg national research Fund
Tech Apr 07, 2025
Europe’s biggest seed rounds of Q1 2025, Enpal bags €110M boost, and Scania acquires bankrupt Northv... — Tech
Europe’s biggest seed rounds of Q1 2025, Enpal bags €110M boost, and Scania acquires bankrupt Northvolt Systems' Industrial Division
Tech Apr 11, 2025

Accure Therapeutics Alternatives & Competitors

Accure Therapeutics vs
Locanabio, Inc.
Locanabio, Inc. United States

Creating RNA-targeting gene therapies to treat devastating diseases

Series B
7 employees
Biotechnology, Health Care
Accure Therapeutics vs
HotSpot Therapeutics, Inc.
HotSpot Therapeutics, Inc. United States

Discovering new allosteric therapies with the ability to treat disease in new ways

Series C
58 employees
Accure Therapeutics vs
Diagonal Therapeutics
Diagonal Therapeutics United States

Diagonal Therapeutics leads in pioneering a fresh method for discovering and advancing agonist antib...

Series B
32 employees
Biotechnology

FAQ About Accure Therapeutics

R&D pharma dedicated to developing innovative medicines to treat patients suffering from Central nervous system diseases
Accure Therapeutics was founded in 2020.
Accure Therapeutics is headquartered in Spain.
Accure Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Accure Therapeutics has approximately 12 employees.
Accure Therapeutics has completed 2 funding rounds, raising a total of $9.20M. The latest funding stage is Grant.
Accure Therapeutics offers: Research and development of innovative medicines for CNS diseases.
Top alternatives and competitors to Accure Therapeutics include Locanabio, Inc., HotSpot Therapeutics, Inc., Diagonal Therapeutics, Lexeo Therapeutics, Ionis Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Accure Therapeutics and Locanabio, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Accure Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy